Original Research

Published on 13 Sep 2022

A novel prognostic biomarker CD3G that correlates with the tumor microenvironment in cervical cancer

in Cancer Immunity and Immunotherapy

Jingshuai Wang
Xuemin Gu
Leilei Cao
Yiqin Ouyang
Xiao Qi
Zhijie Wang
Jianjun Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.979226

2,987 views
7 citations

Review

Published on 13 Sep 2022

Feasibility of hepatocellular carcinoma treatment based on the tumor microenvironment

in Cancer Immunity and Immunotherapy

Haiqiang Wang
Fan Shi
Shudan Zheng
Mei Zhao
Zimeng Pan
Li Xiong
Lihong Zheng

Frontiers in Oncology

doi 10.3389/fonc.2022.896662

3,263 views
1 citation

Original Research

Published on 12 Sep 2022

Urinary incontinence as a possible signal of neuromuscular toxicity during immune checkpoint inhibitor treatment: Case report and retrospective pharmacovigilance study

in Cancer Immunity and Immunotherapy

Yizhang Hu
Wenchao Lu
Borui Tang
Zhixia Zhao
Zhuoling An

Frontiers in Oncology

doi 10.3389/fonc.2022.954468

12,035 views
2 citations

Clinical Trial

Published on 09 Sep 2022

Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer

in Cancer Immunity and Immunotherapy

Baozhen Ma
Yu Zhou
Yiman Shang
Yong Zhang
Benling Xu
Xiaomin Fu
Jindong Guo
Yonghao Yang
Fang Zhang
Mengyuan Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.852885

2,090 views
5 citations

Original Research

Published on 08 Sep 2022

A comprehensive role evaluation and mechanism exploration of POGLUT2 in pan-cancer

in Cancer Immunity and Immunotherapy

Xianyun Xu
Guangming Xie
Mingfeng Xie
Qian Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.962540

2,731 views
3 citations

Review

Published on 05 Sep 2022

Immunotherapies of retinoblastoma: Effective methods for preserving vision in the future

in Cancer Immunity and Immunotherapy

Ling Wang
Shixu Li
Jun Mei
Lin Ye

Frontiers in Oncology

doi 10.3389/fonc.2022.949193

4,546 views
6 citations

Review

Published on 02 Sep 2022

The therapeutic potential of TREM2 in cancer

in Cancer Immunity and Immunotherapy

Elysa M. Wolf
Barbara Fingleton
Alyssa H. Hasty

Frontiers in Oncology

doi 10.3389/fonc.2022.984193

11,297 views
25 citations

Case Report

Published on 02 Sep 2022

Low-dose PD-1 inhibitor combined with lenvatinib for preemptive treatment of recurrence after liver transplantation for hepatocellular carcinoma: Case report and literature review

in Cancer Immunity and Immunotherapy

Xin Jin
Kangjun Zhang
Taishi Fang
Xinchen Zeng
Xu Yan
Jianxin Tang
Ziming Liang
Linjie Xie
Dong Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.951303

2,766 views
6 citations

Original Research

Published on 30 Aug 2022

Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy

in Cancer Immunity and Immunotherapy

Sjoerd P. F. T. Nota
David O. Osei-Hwedieh
David L. Drum
Xinhui Wang
Francesco Sabbatino
Soldano Ferrone
Joseph H. Schwab

Frontiers in Oncology

doi 10.3389/fonc.2022.939166

2,740 views
4 citations

Original Research

Published on 26 Aug 2022

DNA methylation regulators-related molecular patterns and tumor immune landscape in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Dingli Song
Zhenyu Zhou
Jie Wu
Tao Wei
Guang Zhao
Hong Ren
Boxiang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.877817

2,716 views
5 citations

Editorial

Published on 24 Aug 2022

Editorial: Emerging engineering approaches in cancer immunotherapy

in Cancer Immunity and Immunotherapy

Jialu Xu
Xin Ming
Yuanzeng Min
Chao Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1009604

1,575 views
1 citation

Review

Published on 23 Aug 2022

Effect of pulsed field ablation on solid tumor cells and microenvironment

in Cancer Immunity and Immunotherapy

Yujue Wang
Tian’an Jiang
Liting Xie
Huiyang Wang
Jing Zhao
Lei Xu
Chengyu Fang

Frontiers in Oncology

doi 10.3389/fonc.2022.899722

5,592 views
4 citations

Review

Published on 23 Aug 2022

The effects of glucocorticoids and immunosuppressants on cancer outcomes in checkpoint inhibitor therapy

in Cancer Immunity and Immunotherapy

Sebastian Bruera
Maria E. Suarez-Almazor

Frontiers in Oncology

doi 10.3389/fonc.2022.928390

5,668 views
19 citations

Original Research

Published on 22 Aug 2022

Development and validation of a novel fibroblast scoring model for lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Shiyou Wei
Xuyu Gu
Wentian Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.905212

2,959 views
4 citations

Correction

Published on 22 Aug 2022

Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Tingting Deng
Yang Liu
Jialang Zhuang
Yizhe Tang
Qin Huo

Frontiers in Oncology

doi 10.3389/fonc.2022.979968

1,159 views

Original Research

Published on 19 Aug 2022

Respiratory system toxicity induced by immune checkpoint inhibitors: A real-world study based on the FDA adverse event reporting system database

in Cancer Immunity and Immunotherapy

Chanjuan Cui
Lei Deng
Wenqing Wang
Xiayang Ren
Yanfeng Wang
Wei Cui

Frontiers in Oncology

doi 10.3389/fonc.2022.941079

2,875 views
4 citations

Navigation group

Articles

A novel prognostic biomarker CD3G that correlates with the tumor microenvironment in cervical cancer

Feasibility of hepatocellular carcinoma treatment based on the tumor microenvironment

Urinary incontinence as a possible signal of neuromuscular toxicity during immune checkpoint inhibitor treatment: Case report and retrospective pharmacovigilance study

Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer

A comprehensive role evaluation and mechanism exploration of POGLUT2 in pan-cancer

Immunotherapies of retinoblastoma: Effective methods for preserving vision in the future

The therapeutic potential of TREM2 in cancer

Low-dose PD-1 inhibitor combined with lenvatinib for preemptive treatment of recurrence after liver transplantation for hepatocellular carcinoma: Case report and literature review

Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy

DNA methylation regulators-related molecular patterns and tumor immune landscape in hepatocellular carcinoma

Editorial: Emerging engineering approaches in cancer immunotherapy

Effect of pulsed field ablation on solid tumor cells and microenvironment

The effects of glucocorticoids and immunosuppressants on cancer outcomes in checkpoint inhibitor therapy

Development and validation of a novel fibroblast scoring model for lung adenocarcinoma

Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma

Respiratory system toxicity induced by immune checkpoint inhibitors: A real-world study based on the FDA adverse event reporting system database